PARACHUTE China Approval Trial

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.

ClinicalTrials.gov Identifier: NCT02240940

Recruitment Status : Terminated (Company closed)

First Posted : September 16, 2014

Last Update Posted : June 22, 2017

View this study on Beta.ClinicalTrials.gov

Sponsor:

Collaborators:

Guangzhou Chuangsi Medical Technology Co., Ltd.

Peking University

Information provided by (Responsible Party):

CardioKinetix, Inc

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Recruitment Status :	Terminated
Actual Primary Completion Date :	May 2015
Actual Study Completion Date :	June 2017

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Li J, Liu H, Liu Q, Liu C, Xiong W, Ma W, Zhang B, Dong S, Li T. Long-term prognosis analysis of PARACHUTE device implantation in patients with ischemic heart failure: a single-center experience of Chinese patients. J Cardiothorac Surg. 2021 Apr 20;16(1):98. doi: 10.1186/s13019-021-01484-0.

Yang YJ, Huo Y, Xu YW, Wang JA, Han YL, Ge JB, Zhang RY, Yan XY, Gao RL. Percutaneous Ventricular Restoration Therapy Using the Parachute Device in Chinese Patients with Ischemic Heart Failure: Three-Month Primary End-point Results of PARACHUTE China Study. Chin Med J (Engl). 2016 Sep 5;129(17):2058-62. doi: 10.4103/0366-6999.189048.

To Top